Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
2017 · Nature Medicine · 1,560 citations
https://doi.org/10.1038/nm.4345
L
Louise Mannerås-Holm
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
29
Papers
4.1K
Citations
18
h-index
23
i10-index
Louise Mannerås-Holm is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Gut microbiota and health & Metabolism, Diabetes, and Cancer & Adipose Tissue and Metabolism. The author has an h-index of 18, co-authored 25 publications.
ORCID: 0000-0001-8783-6107Papers by this author
worksMicrobially Produced Imidazole Propionate Impairs Insulin Signaling through mTORC1
2018 · Cell · 758 citations
https://doi.org/10.1016/j.cell.2018.09.055
Microbial Imidazole Propionate Affects Responses to Metformin through p38γ-Dependent Inhibitory AMPK Phosphorylation
2020 · Cell Metabolism · 139 citations
https://doi.org/10.1016/j.cmet.2020.07.012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat